Value of Serological Biomarker Panel in Diagnosis of Atrophic Gastritis and Helicobacter pylori Infection.

Background: Gastric cancer is one of the most common types of cancer worldwide. Helicobacter pylori infection is clearly correlated with gastric carcinogenesis. Therefore, the use of a new non-invasive test, known as the GastroPanel test, can be very helpful to identify patients at a high risk, incl...

Descripción completa

Detalles Bibliográficos
Publicado en:Middle East Journal of Digestive Diseases Vol. 15; no. 1; pp. 37 - 45
Autores principales: Sivandzadeh, Gholam Reza, Fard, Saeid Amiri Zadeh, Zahmatkesh, Abbas, Anbardar, Mohammad Hossein, Lankarani, Kamran B.
Formato: algorithm research tables/charts Journal Article
Publicado: Iranian Association of Gastroenterology & Hepatology Jan2023
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=163833503&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 163833503
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        20085230
        BG4K
      jtl: Middle East Journal of Digestive Diseases
      issn: 20085230
      maglogo: N
    pubinfo:
      dt: Jan2023
      vid: 15
      iid: 1
      pid: 70725
      pub: Iranian Association of Gastroenterology & Hepatology
    artinfo:
      ui:
        163833503
        163833503
        163833503
        10.34172/mejdd.2023.318
        163833503
      ppf: 37
      ppct: 8
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Value of Serological Biomarker Panel in Diagnosis of Atrophic Gastritis and Helicobacter pylori Infection.
      aug:
        au:
          Sivandzadeh, Gholam Reza
          Fard, Saeid Amiri Zadeh
          Zahmatkesh, Abbas
          Anbardar, Mohammad Hossein
          Lankarani, Kamran B.
        affil: Gastroenterology and Hepatology Research Center, Internal Medicine Ward, Shiraz Medical School, Shiraz University of Medical Sciences, Iran
      sug:
        subj:
          Gastritis, Atrophic Blood
          Helicobacter Infections Blood
          Biological Markers Blood
          Patient Safety
          Endoscopy
          Biopsy
          Human
          Funding Source
          Cross Sectional Studies
          Iran
          Hematologic Tests
          Immunoglobulins Blood
          Enzyme-Linked Immunosorbent Assay
          Histology
          Urease Analysis
          Male
          Female
          Middle Age
          Descriptive Statistics
          Middle Aged: 45-64 years
          Male
          Female
      ab: Background: Gastric cancer is one of the most common types of cancer worldwide. Helicobacter pylori infection is clearly correlated with gastric carcinogenesis. Therefore, the use of a new non-invasive test, known as the GastroPanel test, can be very helpful to identify patients at a high risk, including those with atrophic gastritis, intestinal metaplasia, and dysplasia. This study aimed to compare the results of GastroPanel test with the pathological findings of patients with gastric atrophy to find a safe and simple alternative for endoscopy and biopsy as invasive methods. Methods: This cross-sectional study was performed on patients with indigestion, who were referred to Motahari Clinic and Shahid Faghihi Hospital of Shiraz, Iran, since April 2017 until August 2017 for endoscopy of the upper gastrointestinal tract. The serum levels of gastrin-17 (G17), pepsinogen I (PGI), and pepsinogen II (PGII), as well as H. pylori antibody IgG, were determined by ELISA assays. Two biopsy specimens from the antrum and gastric body were taken for standard histological analyses and rapid urease test. A pathologist examined the biopsy specimens of patients blindly. Results: A total of 153 patients with indigestion (62.7% female; mean age, 63.7 years; 37.3% male; mean age, 64.9 years) were included in this study. The G17 levels significantly increased in patients with chronic atrophic gastritis (CAG) of the body (9.7 vs. 32.8 pmol/L; P = 0.04) and reduced in patients with antral CAG (1.8 vs. 29.1 pmol/L; P = 0.01). The results were acceptable for all three types of CAG, including the antral, body, and multifocal CAG (AUCs of 97%, 91%, and 88% for body, antral, and multifocal CAG, respectively). The difference in PGII level was not significant. Also, the PGI and PGI/PGII ratio did not show a significant difference (unacceptably low AUCs for all). The H. pylori antibody levels were higher in patients infected with H. pylori (251 EIU vs. 109 EIU, AUC = 70, P = 0.01). There was a significant relationship between antibody tests and histopathology. Conclusion: Contrary to Biohit's claims, the GastroPanel kit is not accurate enough to detect CAG; therefore, it cannot be used for establishing a clinical diagnosis.
      pubtype: Academic Journal
      doctype:
        algorithm
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N